About
Technology
Issues
FAQ
Links
Official Page
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.